Alphabet names Eli Lilly's Ashkenazi as its new CFO

Go back to Alphabet names Eli Lilly's Ashkenazi as its new CFO

Eli Lilly (LLY) PT Raised to $957 at Jefferies

June 6, 2024 4:27 PM EDT

Jefferies analyst Akash Tewari raised the price target on Eli Lilly (NYSE: LLY) to $957.00 (from $925.00) while maintaining a Buy rating.

The analyst comments "Dona's Ad Com documents look fine we note 1) FDA didn't agree w/ LLY on changing primary endpoint but believes data supports... More

Jefferies positive on Alphabet's new CFO, sees potential for stronger returns

June 6, 2024 7:29 AM EDT

Jefferies maintained a Buy rating on Alphabet (NASDAQ: GOOGL) following the appointment of Anat Ashkenazi as CFO, citing her strong track record and potential to unlock shareholder value.

"We believe investors will look positively on GOOGL's appointment," states Jefferies, which has a $200 price target on GOOGL.

They highlight Ashkenazi's impressive tenure at Eli Lilly (LLY), where... More

Alphabet (GOOGL): Anat Ashkenazi to Join Google and Alphabet as Chief Financial Officer

June 5, 2024 7:57 AM EDT

Alphabet Inc. (NASDAQ: GOOG; GOOGL) today announced that Anat Ashkenazi, currently Executive Vice President and Chief Financial Officer at Eli Lilly and Company, will join its management team as Chief Financial Officer and Senior Vice President of Google and Alphabet, effective July 31, 2024.

The company had previously announced in July 2023 that Ruth Porat was commencing a new role as President & Chief Investment Officer of Alphabet and Google. She will continue as CFO until Anat starts, including through the companys Q2 earnings.

Anat Ashkenazi is the... More